美股市场个股详情

SNPX Synaptogenix

添加自选

4.5300
+0.1170+2.65%

收盘价 04/26 16:00 (美东)

4.2400
-0.2900-6.40%

盘后 19:19 (美东)

491.66万总市值-153市盈率TTM

Synaptogenix股票讨论区

登录发表评论

Stock_Drift

04/09 11:34

4/9/2024 Watchlist 🚨⚡️🚨⚡️🚨
$Beneficient(BENF.US)$$Selina Hospitality(SLNA.US)$$Jaguar Health(JAGX.US)$$Edible Garden(EDBL.US)$$Allarity Therapeutics(ALLR.US)$$Synaptogenix(SNPX.US)$
📊⚡️📊

Stock_Drift

04/09 09:00

4/9/2024 🦍Watchlist 🚨⚡️🚨⚡️🚨
$Inspire Veterinary Partners(IVP.US)$$Synaptogenix(SNPX.US)$$Eco Wave Power(WAVE.US)$$Biophytis(BPTS.US)$$CXApp(CXAI.US)$$Brainstorm Cell Therapeutics(BCLI.US)$
📊⚡️📊

MangoXXXX

04/05 21:39

$Synaptogenix(SNPX.US)$ 😎👀

Stock Region

02/23 01:31

Synaptogenix Receives Notice of Allowance for U.S. Patent Application: A Step Forward in the Treatment of Neurodegenerative Diseases.

Synaptogenix, Inc. (NASDAQ: SNPX) has recently made headlines with its significant achievement in the field of neurodegenerative disease treatment. The pioneering biopharmaceutical company has received a Notice of Allowance for its U.S. Patent Application 17/665,033 titled "Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Ne...

赌徒

02/22 05:22

$Synaptogenix(SNPX.US)$ 买进就套上了

Trytosaveabit

02/22 05:04

Update

$Synaptogenix(SNPX.US)$ Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"

Alvinnnnnnngenius

2023/12/06 22:01

$Synaptogenix(SNPX.US)$ Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's